🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Cancer treatments save lives but sometimes can damage the heart or blood vessels. This #CardioSmart infographic will help your patients understand why it's so important to protect their ❤️ before, during & after cancer treatment. bit.ly/2SljiBC #WorldCancerDay

Did You Know? Cancer survivors are 42% more likely to develop cardiovascular disease (CVD) than those who have never had cancer. On #WorldCancerDay, it's important to remember that when the #cancertreatment ends, the healing journey continues. Source: jacc.org/doi/10.1016/j.…

O Grupo de Estudo de Cardio-Oncologia da SPC dá destaque ao estudo “Risk of Incident Heart Failure Among Young Adult Cancer Survivors”. Este estudo alerta para o risco acrescido de insuficiência cardíaca na população dos sobreviventes de cancro, particularmente os submetidos a

The second day of our Cardio-Oncology Course is already underway- great start with the important issue of how to deal with EF reductions during cancer treatment Centro Cardiovascular da Universidade de Lisboa Grupo de Estudo de Cardio-Oncologia medicina

No programa 'Bom Dia Portugal' da RTP1, a Dr.ª Mariana Saraiva, especialista em cardiologia e Vogal do GECO, destacou o risco cardiovascular aumentado nos sobreviventes de cancro, especialmente aqueles submetidos a radioterapia no tórax e alguns tipos de quimioterapia. Durante

#Echofirst #CardioOnc monitoring: LA reservoir strain was not predictive of #Cardiotoxicity in patients with #BreastCancer receiving #anthracycline therapy. bit.ly/3xiqAOs #JACCIMG #BCsm #leusm #lymsm Tom Marwick Kaz Negishi@Cardiologist/ Heart Mafia Chris Y

Enjoyed doing my 1st #cardioonc podcast t.ly/Fdxli with JACC Journals Bonnie Ky dineshpmcc Husam Abdel-Qadir discussing the evidence on 1. #SGLT2i in pts treated with anthracyclines 2. Withdrawal of NHA Therapy in mild #Cancer Therapy-Related Cardiotoxicity #JACCCardioOnc

Dear X #echofirst friends, I am very happy to announce that Echocardio Notes 2.0 is out! 🆕 fresh & clean look ⚪️⚫️ self-adapts to your smartphone theme (light vs dark) ♻️ many corrections, improvements, updates and a lot (!) more notes!

Reverse cardio-oncology meta-analysis – cancer in heart failure (HF) patients. Confirmed significant increased risk of overall cancer compared to controls. Subgroup analysis showed higher risks for specific cancers. Cancer mortality was also higher. revportcardiol.org/pt-the-bidirec…

Excited to announce our latest #CardioOncology research: "HFA-ICOS score predicts anthracycline-related CV toxicity and all-cause mortality". Congratulations to the CardioTox team! academic.oup.com/eurheartj/adva… EHJ Editor-in-Chief CardioQuironMadrid International Cardio-Oncology Society Borja Rivero Santana Jesús Saldaña García Cardiología La Paz

Which Cardiac Troponin do You use in a patient with suspected ICI Myocarditis? Great to share Inova approach in #JACCCardioOnc JACC Journals Dr. Chris Defilippi Raymond Wadlow MD Inova Schar Cancer Institute Inova Schar Heart and Vascular sciencedirect.com/science/articl…

📌The right heart in 👥 with #cancer. A scientific 📝 of the #HFA of the @ESCardio & the ESC Council of #CardioOncology #PositionPaper #RV #EHJHF

SAVE THE DATE!! If interested in #CardioOnc, don’t miss the European Society of Cardiology Cardio-Oncology summit 2025 📅 20-21 June 2025 📍 Florence, Italy 🇮🇹 #ESCCongress #ESCCongress2024

Key messages from the first joint #ESC #ESMO session on #CardioOncology at #ESCCongress2024. Come back to watch the session again: esc365.escardio.org/esc-congress/s…

📋🫀💀 #OpenAccess review article of cardioprotective strategies for anthracycline cardiotoxicity ☠️🫀 Basic Research in Cardiology Free Full Text 👉link.springer.com/article/10.100… #CardioOncology #Cardiotoxicity

The PROACT trial found adding enalapril to standard care during chemotherapy did not prevent cardiotoxicity in patients receiving high-dose anthracycline-based chemotherapy. Read more on the trial: bit.ly/3ZnZWiV #ACCLATAM

#GCOS2024 #JACCCardioOnc SimPub: #SGLT2i administration was associated with a significantly decreased risk of developing cancer therapy-related cardiac dysfunction in patients with #T2DM and cancer. bit.ly/4ebDU7t #GCOS24 #CardioOnc #Diabetes #T2D Ammar Bhatti DO

Not to miss! Miguel Nobre Menezes Sociedade Portuguesa de Cardiologia ICO

Next thursday Nuno Cortez-Dias, MD PhD brings together #CardioOnc and arrhytmias! Register below👇 Sociedade Portuguesa de Cardiologia radcliffecardiology.com/webinars/cardi…

Cancer therapies improve survival—but often at a cost to the heart. This review explores the mechanisms of cardiotoxicity from chemo, radiation, and immunotherapy—and highlights emerging cardio-oncology strategies to improve outcomes (link.springer.com/article/10.100…). #HREV